$1.160
-0.029 (-2.52%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MIST Prediction & Forecast by Similar Chart Analysis
Alphio's MIST stock price prediction model matches the current Milestone Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.14 (-1.83%). The 1-week path is $1.13 (-2.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Milestone Pharmaceuticals Inc Stock?
Milestone Pharmaceuticals Inc is a good buy right now due to its recent positive developments, including a pivotal Phase 3 trial initiation for etripamil, which could significantly enhance its market position. The stock is currently priced at $1.16, and analysts have set a price target of $3, indicating a potential upside of over 150%. Additionally, the company reported a significant increase in prescriptions for its product, with Q2 2026 revenue reaching $559,000, a notable improvement from previous quarters. However, the main risk is the ongoing net losses, with a reported loss of $28.6 million in Q2 2026, which could impact future performance if not addressed.
MIST stock price ended at $1.16 on Friday, after losing -2.52%
Milestone Pharmaceuticals Inc (MIST) last closed at $1.16, losing -2.52%. These facts feed the 1-day and 1-week MIST price prediction above.
Forecast Drivers
Milestone Pharmaceuticals Inc (MIST) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MIST, ranked by similarity.
Seasonality analysis for MIST
Historically the probability of a positive August return for MIST is 0.00%. December offers the highest probability of a positive month at 65.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MIST
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.21 | $1.55 | $1.78 | +33.71% |
| Sep 2026 | $1.66 | $1.84 | $1.87 | +58.66% |
| Oct 2026 | $1.73 | $1.91 | $2.16 | +64.47% |
| Nov 2026 | $1.71 | $1.91 | $2.16 | +64.47% |
| Dec 2026 | $1.71 | $1.89 | $2.13 | +62.73% |
In 2026, Milestone Pharmaceuticals Inc (MIST) is projected to range from $1.21 to $2.16.
Milestone Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Milestone Pharmaceuticals Inc is projected to average $1.55, with a low of $1.21 and high of $1.78.
In Sep 2026, Milestone Pharmaceuticals Inc is projected to average $1.84, with a low of $1.66 and high of $1.87.
In Oct 2026, Milestone Pharmaceuticals Inc is projected to average $1.91, with a low of $1.73 and high of $2.16.
In Nov 2026, Milestone Pharmaceuticals Inc is projected to average $1.91, with a low of $1.71 and high of $2.16.
In Dec 2026, Milestone Pharmaceuticals Inc is projected to average $1.89, with a low of $1.71 and high of $2.13.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.